FMR CORP 13D and 13G filings for Krystal Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 10:32 am Purchase |
2024-11-08 | 13G | Krystal Biotech, Inc. KRYS |
FMR CORP | 4,292,881 14.942% |
943,407 (+28.17%) |
Filing |
| 2024-02-12 12:03 pm Purchase |
2024-02-09 | 13G | Krystal Biotech, Inc. KRYS |
FMR CORP | 3,349,474 11.874% |
963,576 (+40.39%) |
Filing |
| 2024-02-09 09:16 am Sale |
2024-02-08 | 13G | Krystal Biotech, Inc. KRYS |
FMR CORP | 2,385,898 8.458% |
-227,374 (-8.70%) |
Filing |
| 2023-05-10 09:45 am Purchase |
2023-05-09 | 13G | Krystal Biotech, Inc. KRYS |
FMR CORP | 2,613,272 10.133% |
504,419 (+23.92%) |
Filing |
| 2023-02-09 11:18 am Purchase |
2023-02-09 | 13G | Krystal Biotech, Inc. KRYS |
FMR CORP | 2,108,853 8.190% |
130,564 (+6.60%) |
Filing |
| 2022-02-09 09:22 am Purchase |
2022-02-08 | 13G | Krystal Biotech, Inc. KRYS |
FMR CORP | 1,978,289 7.879% |
725,903 (+57.96%) |
Filing |
| 2021-02-08 10:27 am Purchase |
2021-02-05 | 13G | Krystal Biotech, Inc. KRYS |
FMR CORP | 1,252,386 6.354% |
104,100 (+9.07%) |
Filing |